@article{747f33b748e946788f84bf27d4aa0441,
title = "Biologicals in atopic disease in pregnancy: an EAACI position paper",
keywords = "3121 General medicine, internal medicine and other clinical medicine, Allergy, asthma, atopic dermatitis, biologicals, pregnancy, OMALIZUMAB USE, MODIFYING ANTIRHEUMATIC DRUGS, MANAGEMENT, CROHNS-DISEASE, GUIDELINES, allergy, INFLAMMATORY-BOWEL-DISEASE, RITUXIMAB, REGULATORY T-CELLS, ASTHMA, 1ST TRIMESTER",
author = "Birgit Pfaller and Yepes-Nu{\~n}ez, \{Juan Jos{\'e}\} and Ioana Agache and Akdis, \{Cezmi A.\} and Mohammad Alsalamah and Sevim Bavbek and Apostolos Bossios and Onur Boyman and Adam Chaker and Susan Chan and Alexia Chatzipetrou and \{du Toit\}, George and Marek Jutel and Paula Kauppi and Antonios Kolios and Carmen Li and Andrea Matucci and Alanna Marson and Sarah Bendien and Oscar Palomares and Barbara Rogala and Zsolt Szepfalusi and Eva Untersmayr and Alessandra Vultaggio and Thomas Eiwegger",
year = "2021",
month = jan,
doi = "10.1111/all.14282",
language = "English",
volume = "76",
pages = "71–89",
journal = "Allergy : European journal of allergy and clinical immunology",
issn = "0105-4538",
publisher = "Wiley Blackwell",
number = "1",
}